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Objective:Abdominal aortic aneurysm(AAA) is a frequent formofatherothromboticdisease,whosenaturalhistory is toenlargeand
rupture. Indicators other than AAA diameter would be useful for preventive surgery decision-making, including positron-emission
tomography (PET) methods permitting visualization of aortic wall leukocyte activation relevant to prognostic AAA evaluation. In
this study, we compare three PET tracers of activated leukocytes, 18F-fluoro-deoxy-glucose (FDG), 18F-fluoro-methyl-choline
(FCH), and 18F-DPA714 (a peripheral benzodiazepine receptor antagonist) for in vivo PET quantification of aortic wall
inflammation in rat experimental AAAs, in correlation with histopathological studies of lesions.
Methods: AAAs were induced by orthotopic implantation of decellularized guinea pig abdominal aorta in 46 Lewis rats. FDG-PET
(n20), FCH-PET (n8), or both (n12) were performed 2 weeks to 4 months after the graft, 1 hour after tracer injection (30
MBq). Six rats (one of which had FDG-PET) underwent 18F-DPA714-PET. Rats were sacrificed after imaging; AAAs and normal
thoracic aortas were cut into axial sections for quantitative autoradiography and histologic studies, including ED1 (macrophages)
and CD8 T lymphocyte immunostaining. Ex vivo staining of AAAs and thoracic aortas with 18F-DPA714 and unlabeled
competitors was performed.
Results:AAAs developed in 35 out of 46 cases. FCH uptake in AAAs was lower than that of FDG in all cases on imaging, with lower
AAA-to-background maximal standardized uptake value (SUVmax) ratios (1.780.40 vs 2.710.54;P< .01 for SUVmax ratios),
and lower AAA-to-normal aorta activity ratios on autoradiography (3.52  1.26 vs 8.55  4.23; P < .005). FDG AAA-to-
background SUVmax ratios correlated with the intensity of CD8  ED1 staining (r  .76; P < .03). FCH AAA-to-background
SUVmax ratios correlated with the intensity of ED1 staining (r .80; P< .03). 18F-DPA714 uptake was similar in AAAs and in
normal aortas, both in vivo and ex vivo.
Conclusions: In rat experimental AAA, characterized by an important aortic wall leukocytes activity, FDG-PET showed higher
sensitivity than FCH-PET and 18F-DPA714-PET to detect activated leukocytes. This enhances potential interest of this tracer for
prognostic evaluation of AAA in patients. (J Vasc Surg 2012;56:765-73.)
Clinical Relevance: The decision for preventive surgery of abdominal aortic aneurysm (AAA) is based on clinical signs and AAA
diameter. However, AAA progression is not linear; growth acceleration usually precedes rupture. Therefore, other indicators of
lesion development would be useful for surgical decision-making. Adventitial inflammation has been linked to AAA enlargement.
Therefore, positron-emission tomography (PET) imaging quantifying activated leukocytes in aortic wall could be useful for
prognostic evaluation of AAAs. In this experimental study comparing three main PET tracers of activated leukocytes, we show that
18F-fluoro-deoxy-glucose has the highest sensitivity of detection and appears the most promising for clinical use in this setting.
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September 2012766 Sarda-Mantel et alAbdominal aortic aneurysm (AAA) is a frequent form
of atherothrombotic disease, anatomically characterized by
focal dilatation resulting in an expanded, beating abdomi-
nal mass.1,2 Currently, the decision for preventive surgery is
based on clinical signs and anatomic criteria: a diameter
superior to 5.5 cm, or a diameter increase on echography or
computed tomography (CT). However, AAA progression
is not linear,3,4 and growth acceleration usually precedes
rupture. Therefore, indicators of lesion development other
than AAA diameter would be useful for surgical decision-
making.
Many biological processes, including activity of parietal
thrombus,5 adventitial innate, and adaptive immune re-
sponse6 angiogenesis and activity of proteases, have been
linked to AAA enlargement. That is why, besides anatomic
imaging, molecular imaging targeting these biological pro-
cesses could have a potential interest for patients’ manage-
ment. Positron-emission tomography (PET) imaging per-
mitting quantification of leukocytes extravasations and
accumulation in aortic wall could be especially useful for
prognostic evaluation of AAAs.7
Currently, three PET tracers of inflammatory cells are
candidates for clinical use in atherosclerosis: 18F-fluoro-
deoxy-glucose (FDG), 18F-fluoro-methyl-choline (FCH),
and 18F-DPA714 (DPA), a peripheral benzodiazepine recep-
tor antagonist. FDG is a radiotracer of cellular glucosemetab-
olism, with high sensitivity of detection in malignant tumors
and inflammatory diseases (96% inmild chronic septic inflam-
mation).8 Despite controversial specificity with regard to ar-
terial wall leukocyte content,9 which has been related to
occurrence of clinical events, it is actually under intense clinical
investigation in atheroma and AAAs as a prognostic mark-
er.10-13 FCH, which targets choline transport and cell mem-
brane incorporation, is clinically used to detect prostate can-
cers. It can detect inflammatory cells in murine and human
atherosclerosis,14,15 but its sensitivity has not been evaluated
in patients. High-affinity radioligands specific for peripheral
benzodiazepine receptors, including 18F-DPA714, have
been successfully used to target tissue leukocytes in animal
models of neuroinflammation.16,17 Their sensitivity for the
detection of inflammatory diseases in patients has not been
evaluated.
The aim of the present work was to compare the
sensitivity of these three tracers for the detection of aortic
wall leukocytes accumulation in vivo in an experimental
model of immune-induced aortic aneurysm in rats,18 and to
verify their specificity with regard to leukocytes content.
The results of this preclinical study will guide further clin-
ical study in this setting.
METHODS
Animal model
Experimental AAAs were induced by the orthotopic
implantation of a segment (1.5 cm) of sodium dodecyl
sulfate (SDS)-decellularized guinea pig abdominal aorta
(xenogenic matrix) in Lewis rats, under anesthesia (50
mg/kg intraperitoneal injection [IP] ketamine [Imalgène a00; Merial, Lyon, France] and 10 mg/kg IP xylazine [2%
ompun, Bayer, Puteaux, France]), according to the pre-
iously described method.18 The procedure and the animal
are complied with the principles formulated by the Na-
ional Society for Medical Research. This study was per-
ormed under the authorization # 75-214 of the French
inistry of Agriculture. The host’s immunoinflammatory
esponses to the engrafted extracellular matrix induce vas-
ular remodeling leading to formation of an aneurysm with
n intraluminal thrombus.19 This xenograft model is char-
cterized by important accumulation of CD8 lympho-
ytes and macrophages within the grafted aortic wall,20,21
hich is at maximum at 2 weeks then decreases while AAA
iameter increases. Also, the activation markers ICAM-1
nd LFA-1 correlate with the density of total inflammatory
ells,20 and are at maximum at day 15 then decrease.
herefore, it is relevant to the adventitial immune response
bserved in outer media and adventitia of human AAA.6
ET imaging
PET imaging was performed at different times after the
raft, from early phase (11-14 days) to several months, to
e able to verify a correlation between the intensity of PET
ignal and the density of inflammatory cells in the aneurys-
al parietal wall (specificity of the targeting). FDG-PET
nd FCH-PETwere performed on the same imaging device
n Tenon Laboratory. Dual FDG- and FCH-PET was
lanned in 20 animals for direct comparison of perfor-
ances, but it could only be performed in 12 rats because
f frequent timely delivery issues for FCH (only FDG-PET
as done). Additional rats were used with either FDG or
CH for the correlation between PET imaging and immu-
ohistology. For legal reasons, DPA-PET imaging was
erformed on the site of tracer production (Orsay).
8F-FDG
FDG-PET was performed once in 32 operated rats,
rom 11 days to 4 months after the graft. Four sham-
perated rats also underwent FDG imaging. PET examina-
ions were performed on a Mosaic small animal PET
Philips, Cleveland, Ohio). This system has a 2.2-mm res-
lution at the center of the field of view. The energy
indow was 450 to 700 keV, and the coincidence timing
indow was 6 ns. Data were acquired in 3D mode and
orrected for decay and randoms. A single bed acquisition
as sufficient to image the whole abdomen and pelvis of
nimals. Reconstruction was performed using the 3D row
ction maximum likelihood algorithm. Attenuation correc-
ion was not applied. Following at least 6 hours fasting, the
ats under anesthesia (2% isoflurane in 100% O2) received
n average activity of 30 MBq of FDG (Flucis [Cis Bio,
rsay, France] or Efdege [Iason, Seiersberg, Austria])
hrough a vein injection. The residual dose wasmeasured to
erify the effective dose injected. Before, during, and after
DG injection, animals were kept under an infrared light to
inimize brown fat visualization. PET examinations (static
cquisition of 20-minute duration) were performed 1 hour
fter injection.
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FCH-PET was performed in 20 operated rats, from 2
weeks to 4 months after the graft, including 12 that also
had FDG-PET the day before (six rats) or after (six rats)
FCH-PET, on the same microPET device, using the same
protocol except that three static images of 20-minutes
duration were performed at 20 minutes, 40 minutes, and 1
hour after FCH injection (30MBq Iasocholine [Iason]), to
determine the time of highest signal-to-noise ratio.
18F-DPA714
DPA-714N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-
5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-yl)acetamide was
labeled with fluorine-18 using a tosyloxy-for-fluorine nucleo-
philic aliphatic substitution. This simple one-step process in-
volves reaction of K-18F-F-Kryptofix222 with the tosyloxy
precursor (4.5-5.0mg, 8.2-9.1mol) at 165°C for 5minutes
in dimethyl sulfoxide (0.6 mL), followed by C-18 PrepSep
cartridge (Fisher Scientific, Strasbourg, France) prepurifica-
tion, and finally semipreparative high-pressure liquid chroma-
tography purification on an X-Terra RP18 (Waters, Guyan-
court, France). 18F-DPA714 (95% radiochemically pure)
was obtainedwithin 90minutes of radiosynthesis with specific
radioactivity of 185 MBq/mol. Six grafted rats (one of
which had FDG-PET the day before) underwent 18F-
DPA714-PET on an ECAT high-resolution research tomo-
graph PET system (Siemens Medical Solutions, Knoxville,
Tenn, spatial resolution 2.3 mm), 2 weeks to 1 month after
the graft. 18F-DPA714 (20 MBq) was injected into anesthe-
tized rats (2% isoflurane in 100% O2), and mod-list whole-
body PET acquisition was performed from the time of injec-
tion to 3 hours and 30 minutes postinjection. Then, 10
images of 20-minute duration were reconstructed frommod-
list acquisition, including one at 1 hour postinjection. The raw
data were reconstructed using an ordered subset expectation
maximization weighted attenuation with six iterations and
eight sub subsets, including a Fourier rebinning.
Data analysis. PET images were considered positive
(visual analysis) when increased tracer uptake was seen in the
abdominal aortic aneurysmal wall compared with the subja-
cent normal aorta. Quantification was performed on the 20-
minute duration images obtained 1 hour after injection of the
tracers. Two-dimensional regions of interest (ROIs) were
drawn on the infrarenal aortic wall (when visible) and in
surrounding soft tissue (background activity). Maximal stan-
dard uptake values (SUVmax; ratio of tissue radioactivity con-
centration [kBq/mL] at time t and injected dose [MBq] at
the time of injection divided by body weight [kg]) were
determined in ROIs, and SUVmax ratio between the aortic
wall and surrounding soft tissue was calculated for each axial
slice. For data analysis, we used the mean value obtained for
SUVmax and AAA/background SUVmax ratio in four consec-
utive axial slices. The latter parameter is derived from that
validated for quantification of inflammation with FDG-PET
in carotid atherosclerotic plaques of patients.11,22 autoradiography
All ratswere sacrificed after imaging.A ringof the thoracic
nd the infrarenal aortas were dissected out, frozen, and cut
nto transverse sections of 20-m thickness, which were ex-
osed in a radioimager (Instant Imager, Packard Instrument
o, Meriden, Conn) for 16 hours. The activity (total counts
er section) was determined on autoradiograms.
Also, axial and transversal sections of AAA and normal
horacic aorta of three noninjected rats were incubated with
ither 18F-DPA714, 18F-DPA714 mixed with a 100-fold
xcess of PK11195 (another peripheral benzodiazepine re-
eptor [PBR] antagonist), or 18F-DPA714 mixed with an
xcess (20 mmol) of unlabeled DPA714, for ex-vivo radiola-
eling of leukocytes. Sections were incubated for 20 minutes
n Tris Buffer (Sigma, Saint-Quentin Favallier, France), ad-
usted at pH 7.4 at 41°C, and then rinsed for 2 minutes with
old buffer, followed by a quick wash in cold distilled water.
ections were then placed in direct contact with a Storm 860
hosphor-Imager screen (GMI Inc, Ramsey, Minn) and ex-
osed overnight. Autoradiograms were analyzed using the
mageQuant software (GMI Inc).
istologic studies
Sections used for autoradiography were stained with
ematoxylin-eosin. Immunostaining for rat CD8 T lym-
hocytes (anti-CD8, AbD Serotec, Düsseldorf, Germany)
nd rat macrophages (anti-ED1, AbD Serotec) was per-
ormed on 8-m tissue sections, according to the manufac-
urer’s instructions. Immunostaining of all rat sections was
erformed at the same time. Briefly, tissue sections were
xed in acetone, treated by TRIS EDTA at 95°C for 30
inutes, then H2O2 for 1 hour, avidin biotin for 10
inutes, and finally 1% bovine serum albumin in TRIS for
0 minutes. The primary Ab anti-ED1 (1/100) or anti-
D8 (1/50) was applied overnight. After rinsing, the
econdary Ab (BA2001 1/1000 et al 1/100) was applied
nd then revealed with 3,3’-diaminobenzidine (10 min-
tes). Positive controls using rat spleen sections and nega-
ive controls using mouse IgG1 instead of anti-ED1 and
nti-CD8 primary antibodies were performed simultane-
usly. The number of positive cells per mm2 of myocardial
ection was estimated by light microscope at 400-fold
agnification in one section per rat, using Histolab quan-
ification software.
tatistical analysis
Comparison of SUVmax and signal-to-noise ratios on
ET images, as well as of AAA-to-normal aorta activity
atios on autoradiography, were performed between ani-
als with AAAs and sham-operated rats, and between FDG
nd FCH, using the Student t-test. The level of significance
as set at 0.05. A correlation regression test was used to
ompare the distributions of SUVmax or AAA-to-back-
round SUV ratios and those of AAA diameter, timemax
fter the graft, and ED1 or CD8 quantifications.
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AAAs developed in 35 of 46 operated rats (diameter,
2-15 mm; length, 7-20 mm; control diameter, 1.1 mm).
The transaxial diameter of AAAs imaged with both FDG
and FCH was similar to that of AAAs imaged with DPA
(4.4  1.5 vs 4.3  0.4 mm; P  NS).
Twenty-eight of the 32 rats that underwent FDG-PET
Fig 1. A, Positive fluoro-deoxy-glucose (FDG)-positro
aneurysm (AAA). a, FDG-PET imaging in a rat with AAA
compared with normal aorta. b, FDG-PET in a sham-o
abdominal aorta. c, Autoradiography of AAA (left) and n
B, Positive fluoro-methyl-choline (FCH)-PET in a rat w
Autoradiography of AAA (left) and normal aorta (right).
C, Comparison of FDG and FCH uptakes on PET imag
is lower than that of FDG, with lower SUVmax and
autoradiography. ANR, AAA-to-normal thoracic aorta
SUVmax ratio on PET imaging. *FDG and FCH imaginhad an AAA at sacrifice. Visual analysis of images revealed ancreased FDG uptake in AAA wall in 25 cases (SUVmax 1
our postinjection, 1.73  0.53; Fig 1, Aa), and no
ncrease in three cases (SUVmax, 1.04 0.18; AAAs of 4-5
m diameter). SUVmax was 0.9 0.1 in infrarenal aorta of
rafted rats with no AAA. SUVmax in background tissue
urrounding abdominal aorta was 0.60  0.12.
Fifteen of the 20 rats that underwent FCH imaging had
ission tomography (PET) in a rat with abdominal aortic
reased FDG uptake (arrows) is seen in AAA parietal wall
ed rat; no increased FDG uptake is observed in normal
l aorta (right); intense FDG uptake is observed in AAA.
AA (arrow). a, PET axial view. b, PET frontal view. c,
ity ratio between AAA and normal aorta sections is 3.1.
and autoradiography. FCH uptake in AAA parietal wall
ratios on PET imaging, as well as lower ANR on
ty ratio on autoradiography; T/B, AAA-to-background
he same rats.n-em
. Inc
perat
orma
ith A
Activ
ing*
T/B
activin AAA at sacrifice. Visual analysis of images revealed
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Volume 56, Number 3 Sarda-Mantel et al 769increased FCHuptake in AAAwall in 10 of 15 AAAs, which
was not modified between 20 minutes and 1 hour postin-
jection (SUVmax 1 hour postinjection, 1.31  0.33; Fig 1,
Bb), and no increase in five rats (SUVmax 1 hour post-
injection, 0.83  0.16; 3-8 mm diameter). SUVmax was
0.5  0.1 in infrarenal aorta of grafted rats with no AAA.
SUVmax in background tissue surrounding abdominal aorta
was 0.64 0.05. In the 12 rats that underwent both FCH
and FDG imaging, FCHuptake in AAAwas lower than that
of FDGon visual analysis of PET images (Fig 1, Ba and Bb),
including two AAAs with negative FCH scan and positive
FDG scan; and both SUVmax in AAAs and AAA-to-
background SUVmax ratios on FCH-PET were lower than
on FDG-PET (Fig 1, C).
Autoradiographic studies demonstrated that FDG and
FCH activity were located in the AAA wall (Fig 1, Ac and
Bc). FCH AAA-to-normal aorta activity ratios on autora-
diography were lower than that of FDG (Fig 1, C).
Globally, uptake of both FDG and FCH in parietal walls of
AAAs (measured on PET images or autoradiography) decreased
Fig 2. Evolution of fluoro-deoxy-glucose (FDG) (left
uptakes in abdominal aortic aneurysms (AAAs) as functiwith AAA diameter and with time after the graft (Fig 2). CAll six rats injected with 18F-DPA714 had AAA, and all
ad negative PET images. One of them also underwent
DG-PET, which was positive. 18F-DPA714 uptake in
AAs was not different from that observed in the wall of
ontrol normal aortas (Fig 3, A). This was confirmed by
utoradiography, which demonstrated significant tracer ac-
ivity in the wall of both AAA and normal thoracic aorta,
ith 18F-DPA714 aneurysm-to-normal aorta activity of
nly 2.0 0.4. Ex vivo studies confirmed tracer binding to
oth AAA and normal aortic wall, which was inhibited by
1C-PK11195, and unlabeled DPA714 (Fig 3, B).
Immunohistological studies demonstrated ED1
onocyte-macrophages and CD8 T lymphocytes in the
dventitia of all AAAs (Fig 4). ED1 staining varied from
90 to 2194 positive cells per AAA sections, CD8 stain-
ng varied from 6 to 2029, and total stained cells per
ection varied from 428 to 6342. We found a significant
orrelation between FDG SUVmax or AAA-to-back-
round SUVmax ratios and the number total stained cells
CD8 ED1) reflecting numbers of both macrophages and
n) and fluoro-methyl-choline (FCH) (right column)
AAA diameter and time after the graft.columD8 T lymphocytes in the AAA section (r .76; P .03;
r
c
F
t
e
p
a
s
d
s
a
(
m
l
t
a
s
S
n
b
n
s
i
C
n
p
a
s
wall
JOURNAL OF VASCULAR SURGERY
September 2012770 Sarda-Mantel et alFig 4). No significant correlation was found between FDG-
SUVmax and ED1, or CD8 staining separately. Using FCH,
AAA-to-background SUVmax ratio significantly correlated
with ED1 (macrophages) staining (r  .80; P  .03; Fig 5).
AAAs with negative FDG-PET that were quantified (n  2)
had 428 and 531 stained cells per section; one with negative
FCH-PET had 926 stained cells per section. Grafted rats with
no AAA that were quantified had 467 and 3342 stained cells
per section of infrarenal aorta.
DISCUSSION
In this rat model of AAA (aortic xenograft), FDG- and
FCH-PET signals in the AAA wall correlated significantly with
the quantity of macrophages and CD8 lymphocytes. FDG up-
take inAAAswashigher than that innormal aorta in all cases, and
higher than that of FCH uptake. 18F-DPA714-PET was not
significantly different in AAAs and in normal aorta.
18F-FDG imaging of inflammatory lesions.
Glucose and FDG uptake are increased in activated mono-
cytes and lymphocytes.23,24 FDG accumulation correlates
with the number and activity of gluclose transporters (GLUT)
1 and GLUT 3.24 Expression of GLUT 1 and GLUT 3 is
augmented 3.5- and six-fold, respectively, in lymphocytes
following activation by phytohemagglutinin.23 GLUT 1 ex-
pression is increased two-fold in monocytes upon activation
with lipopolysaccharide, with a two- to three-fold increase in
glucose influx.23 In vivo, it has been shown in mouse models
of chronic enterocolitis that the FDG signal is only related to
activated T lymphocytes and not to nonactivated ones.25 As
Fig 3. Examples of 18F-DPA714 positron-emission tom
PET frontal view of a rat with inflamed abdominal aortic a
uptake is observed in AAA and subjacent iliac arteries. B, E
panel) in another rat; high 18F-DPA714 uptake is obs
disappears in the presence of unlabeled PK11195 (b)
benzodiazepine receptors in both AAA and normal aortaobserved in our experimental AAAs, significant FDGuptakewas reported in human AAAs, corresponding to adventitial lympho-
yte granuloma on histology, whereas the mural thrombus was
DG-negative.12,13 Many authors have studied the relation be-
ween FDGuptake in leukocyte-rich lesions and the presence of
ithermonocyte-macrophages,CD4 lymphocytes, orCD8 lym-
hocytes in atherothrombotic plaques,26-28 mammary tumors,
nd chemotherapy-induced pneumopathies, with various and
ometimes discordant results. In a recent experimental study,
iscrepancies were found between signals measured on athero-
clerotic aorticwallwithN1177, aCTmarkerofphagocytic cells,
nd FDG-PET.27 Such differences may be due to the facts that:
1) FDG uptake depends on both the density and the glucose
etabolism of the cells; (2) when several types of cells in the
esion are activated, FDGuptake is related to the total number of
hem. In our model, Allaire et al previously showed that the
ctivationmarkers ICAM-1 and LFA-1 correlated with the den-
ityof total inflammatorycells.20Accordingly inour study,FDG-
UVonly correlatedwith summedED1 andCD8 cells, but
ot to either ED1 or CD8 cells separately, suggesting that
oth monocytes and lymphocytes are involved in the FDG sig-
al. It is also probable that other cell types, such as lymphocyte
ubtypes, activatedendothelial cells,orfibroblasts, alsoparticipate
n FDG uptake in lesions.
18F-FCH imaging of inflammatory lesions.
holine is taken up into cells by specific transport mecha-
isms, phosphorylated by choline kinase, metabolized to
hosphatidylcholine, and incorporated into the intracellular
nd plasma membranes.29 Increased choline uptake has been
hown in tumors and soft tissue infection30 and in atheroscle-
phy (PET) and autoradiographic data. A, 18F-DPA714
sm (AAA), 30 to 60minutes postinjection; similar tracer
o labeling of AAA (upper panel) and normal aorta (lower
in both tissues with comparable intensity (a), which
PA714 (c), indicating specific labeling of peripheral
.ogra
neury
x viv
erved
or Dotic plaques.14,15 It is a cell proliferation marker, since both
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Volume 56, Number 3 Sarda-Mantel et al 771Fig 4. Immunohistology of an abdominal aortic aneurysm (AAA). Adventitial CD8 (A) and ED1 (B) stainings in a
large AAA. a, Negative control. b, Corresponding stained area. c, Whole AAA section staining.Fig 5. Relation between positron-emission tomography (PET) images quantification and number of leukocytes on histology.
T/B ratio, Ratio of SUV in abdominal aortic aneurysm (AAA) to SUV in surrounding tissue vs CD8; ED1, number ofmax max
stained cells per tissue sections.
v
d
p
c
w
c
w
m
i
m
b
d
u
w
S
b
t
t
a
e
r
i
l
n
fi
m
p
i
(
a
t
l
C
t
h
c
c
v
N
L
A
C
A
D
W
C
F
S
O
JOURNAL OF VASCULAR SURGERY
September 2012772 Sarda-Mantel et alcholine transporters and choline kinase, which triggers the
metabolic pathway leading to choline incorporation into
membranes, are upregulated in highly proliferative cells.31
However, choline influx was also evidenced inmurine macro-
phages stimulated by colony stimulating factor-1, and in hu-
manmonocytic THP-1 cells in vitro.32 According to our data,
a good correlation was previously found between FCH or
11C-choline accumulation and ED1 staining in murine ath-
erosclerotic plaques ex vivo.14,33,34 Moreover, Matter et al
also reported that the FCH signal is better correlated to the
presence of macrophages than that of FDG. But our results
point out the fact that target-to-background ratios on FCH-
PET are inferior to those obtained with FDG in AAAs. We
found less accumulation in lesions, possibly because of a lower
uptake of choline than glucose in activated cells, as previously
reported in experimental aseptic inflammation.30
18F-DPA714 imaging of inflammatory lesions.
PBRs are heterotrimers (isoquinoline binding protein; a volt-
age-dependent anion channel and an adenine nucleotide
transporter) located primarily on mitochondrial membranes
of various cells, especially glial cells in the brain, and inflam-
matory cells.35 In experimental cerebral ischemia, high densi-
ties of PBR correlate with the infiltration of macrophages.
DPA (N,N-diethyl-2-[2-(4-methoxyphenyl)-5,7dimethyl-
pyrazolo[1,5-a]pyrimidine-3-yl]acetamide) was recently de-
veloped as a PBR ligand and radiolabeled with C-11
(DPA713) and F-18 (DPA714).16,17 Our data suggest spe-
cific 18F-DPA714uptake in both inflammatoryAAAwall and
in normal aortic wall. Indeed, PBRs are abundant in endothe-
lial cells, striatedmuscle cells in the heart, smoothmuscle cells
of the blood vessels, and mast cells35; this probably explains
our findings as also suggested by Laitinen et al in mice.36 In
another report, an increase in PBR density was reported in
human atheromatous plaque using 3H-PK11195 autora-
diography after endarterectomy,37 but no comparison to nor-
mal aorta could be made in this study. Very recently, in vivo
detection of giant cell arteritis and Takayasu arteritis were
reported using 11C-PK11195 PET in seven patients38,39 that
had not been evidenced usingFDG.Thediscrepancy between
the results in these patients and the present study in rats may
be explained by a difference in PBR expression according to
the type of cells in lesions (macrophages and lymphocytes in
rat aneurysms,giantmultinucleatedcells andactivatedfibroblasts
ingiant cell arteritis andTakayashuarteritis), or adifference in the
molecular targets of 11C-PK11195 and 18F-DPA714.
Potential clinical relevance of our findings. Human
AAA is a spatiotemporal model of atherothrombotic disease,
including an intraluminal thrombus, aortic wall degradation,
angiogenesis, and adventitial inflammatory response,6 which
all have been linked to AAA enlargement.40 Our rat model is
relevant to all of these processes, especially to the adventitial
immune response observed in outer media and adventitia (pre-
dominantlymononuclear cells, including lymphocytes).6,20 Like
in atherosclerotic plaques, the question of clinical interest is
whetherornotbiological processes (especially leukocytes infiltra-
tion and activation that lead to release of proteases) are active or
not inAAAparietalwall (ie, ifAAAis at risk for rapidenlargement
or not).12 Because of its higher sensitivity of detection, FDG is a Oery good candidate for activated leukocytes imaging in AAA
espite a lower specificity thanFCH.In theory, thebest tracer for
rognostic evaluationofAAA inpatientswouldbe theonebetter
orrelated to AAAdevelopment. To this issue, encouraging data
ere previously reported suggesting that FDG is linked tomyo-
ardial infarction and stroke in atherosclerotic patients,10,11 as
ell as to AAA evolvement.12,13 Other radiotracers, such as
arkers of thrombotic or fibrinolytic activity, may also be of
nterest topredict riskof atheroscleroticplaques andAAAevolve-
ent,19 especially 99mTc-annexinA5.41,42But theywill have to
e compared to FDG and FCH, both in terms of sensitivity of
etection and prediction of events.
Limits of the study. Partial volume effects induce an
nderestimation ofmeasurements in PET images (no correction
as applied in this study), probably inducing underestimation of
UVmax values in infrarenal aortaof thegraftedratswithnoAAA,
ecause of very thin aortic wall (1mm). Attenuation correc-
ion of PET images could not be applied. Despite these limita-
ions, signals could be seen, quantified, and well-correlated with
utoradiography and histology. For FDG and FCH, the param-
ter that correlated best with leukocytes accumulation was the
atio of SUVmax inAAAwall to SUVmax in adjacent soft tissue. It
spossibly lessaccurate thanSUVmax inAAA/SUVmean inarterial
umen,which is a good criteria in patients.28However, we could
ot obtain such measures since the cardiac area was out of the
eld of view, and the rat aortic lumen is too small for accurate
easurements. ForDPA714, the reason fornodetection ismost
robably related to high specific binding in normal aorta impair-
ng discrimination between normal and inflamed aortic wall
aneurysm-to-normal aorta activity ratio was only 2.0 0.4 on
utoradiography) than to methodological reasons. It is possible
hat imaging in patients performs better than in rats because of
arger size of organs.
ONCLUSIONS
In rat experimental AAA, characterized by an impor-
ant aortic wall leukocytes activity, FDG-PET showed
igher sensitivity than FCH-PET to detect activated leuko-
ytes, and 18F-DPA714-PET was negative probably be-
ause of high PBR density in both normal and pathologic
essel walls as evidenced on ex-vivo tissue binding assays.
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